I-ESC CVD Risk Calculation App yakhelwe ochwepheshe bezempilo. Ihlinzeka ngezibalo ezihlola ingozi ngayinye yenhliziyo nemithambo yegazi. Kubandakanya izibali zokuvimbela okuyisisekelo nesesibili kubantu abahlukahlukene:
SCORE2
I-SCORE2-OP
I-SCORE2-Isifo sikashukela
I-ASCVD
I-SMART
SMART-REACH*
DIAL*
I-LIFE-CVD*
* Itholakala ku-inthanethi ku-U-Prevent (Kudingeka ukuxhumana kwe-inthanethi)
I-ESC CVD Risk Calculation App itholakala ngesiNgisi. Inikeza isiqondiso kumshini wokubala ojwayeleke kakhulu wesiguli sakho, futhi inikeza isilinganiso sengozi yenhliziyo nemithambo yegazi. Okuqaphelekayo, idatha yesiguli ayigcinwa ku-App.
Lolu hlelo lokusebenza lusetshenziselwa ulwazi kuphela futhi aluhloselwe ukunikeza ukwesekwa kwezokwelapha noma usizo lokuxilongwa.
Lolu hlelo lokusebenza luxhaswe yi-European Society of Cardiology (ESC), ngokusekelwe kumakhodi omthombo we-U-Prevent webtool, umqondo othuthukiswe yi-University Medical Center Utrecht, eklanywe kabusha futhi ephethwe yi-ORTEC.
Izibali ze-SCORE2, SCORE2-OP kanye ne-SCORE2-Diabetes zathuthukiswa ngokubambisana neyunithi ye-ESC Cardiovascular Risk Collaboration.
Isicelo sisanda kubuyekezwa kuhlaka lwe-EAPC IMPLEMENT Programme (2023) olwasekelwa i-Novo Nordisk ngendlela yesibonelelo semfundo. Umxhasi akazange abe nokubandakanyeka noma ukuthonya izici noma kokuqukethwe kwesayensi ngaphakathi kwesicelo.
Kubuyekezwe ngo-
Jan 3, 2024